Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation"
ContributorsBouatou, Yassine; El Biali, Myriam; Samer, Caroline Flora
Published inCirculation, vol. 134, no. 2, p. e3-4
Publication date2016
Abstract
Keywords
- CYP3a
- Drug drug interaction
- Atrial Fibrillation
Citation (ISO format)
BOUATOU, Yassine, EL BIALI, Myriam, SAMER, Caroline Flora. Letter by Bouatou et al Regarding Article, ‘Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation’. In: Circulation, 2016, vol. 134, n° 2, p. e3–4. doi: 10.1161/CIRCULATIONAHA.116.022034
Main files (1)
Article (Published version)
Identifiers
- PID : unige:85403
- DOI : 10.1161/CIRCULATIONAHA.116.022034
- PMID : 27400900
Journal ISSN0009-7322
